Galectin-1 enhances astrocytic BDNF production and improves functional outcome in rats following ischemia

62Citations
Citations of this article
51Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Galectin-1, an endogenous mammalian lectin, has been implicated in a variety of CNS disorders. However, its role in cerebral ischemia is still elusive. In the present study, we investigated the effect of recombinant galectin-1 on production of astrocytic brain-derived neurotrophic factor (BDNF) and functional recovery following ischemia. Endogenous galectin-1 was found to be markedly upregulated, paralleled with increased astrocytic BDNF production under ischemic conditions both in vitro and in vivo. Administration of galectin-1significantly enhanced the expression and secretion of astrocytic BDNF in dose dependent manner. Moreover, rats subjected to photochemical cerebral ischemia showed reduced neuronal apoptosis in ischemic boundary zone and improved functional recovery after brain infusion of galectin-1 (1 μg/days, 7 days). These results suggest that induction of BDNF in astrocytes by galectin-1 may be a promising intervention to attenuate brain damage after stroke. © 2010 Springer Science+Business Media, LLC.

Cite

CITATION STYLE

APA

Qu, W. S., Wang, Y. H., Wang, J. P., Tang, Y. X., Zhang, Q., Tian, D. S., … Wang, W. (2010). Galectin-1 enhances astrocytic BDNF production and improves functional outcome in rats following ischemia. Neurochemical Research, 35(11), 1716–1724. https://doi.org/10.1007/s11064-010-0234-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free